Clinical Trials Logo

Clinical Trial Summary

An EONS occurred in nearly 14-22 % of the preterm infant of pregnant women with PPROM. To this day no risk prediction is established. The main aim of this pilot study is generating primary data with a focus on the vaginal microbiome to set-up a prospective, multi-centre trial investigating the role of the vaginal microbiome for future EONS risk prediction. The planned PEONS pilot trial is subdivided in three Work packages: 1. Recruitment, sample collection and routine clinical diagnostics 2. Microbiome analysis by 16S rRNA 3. Microbiome/ Metagenome analysis by "Nanopore" (proof-of-principle) and will enroll women with a PPROM event hospitalized between 22+0 and 34+0 weeks of gestation and neonates with signs of EONS (Subgroup 1) and without signs of EONS (Subgroup 2).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03819192
Study type Observational
Source Jena University Hospital
Contact Ekkehard Schleußner, Prof. Dr.
Phone +49 3641
Email gabriele.schack@med.uni-jena.de
Status Recruiting
Phase
Start date February 1, 2019
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT06076200 - Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations
Completed NCT03694613 - Utility of Placental/Umbilical Cord Blood in Early Onset Neonatal Sepsis in Very Low Birth Weight Infants N/A
Recruiting NCT03997266 - NICU Antibiotics and Outcomes Trial Phase 4
Recruiting NCT05329701 - Individualized Duration of Antibiotic Treatment in Early Onset Infection in Newborns. Phase 4
Not yet recruiting NCT06377397 - Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates Phase 3
Recruiting NCT06197269 - Efficacy And Safety Of Short Course Antibiotic Therapy In Preterm Neonates With Early Onset Sepsis N/A
Not yet recruiting NCT06100614 - Presepsin to Safely Reduce Antibiotics in Preterm Infants N/A
Not yet recruiting NCT05796115 - PROcalcitonin and Presepsin-guided Decision for Antibiotic Prophylaxis of EOS N/A